|By PR Newswire||
|July 30, 2014 12:54 PM EDT||
DUBLIN, July 30, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Hematology Analyzers & Reagents Market - Forecasts to 2019" report to their offering.
The global hematology market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years.
The growth of the hematology analyzers and reagents market is driven by factors such as increasing adoption of automated hematology instruments by diagnostics laboratories, growing development of the high throughput hematology analyzers, integration of basic flow-cytometry techniques in modern hematology analyzers, developments in high sensitivity Point-of-Care hematology testing, and the introduction of technologically advanced hematology instruments.
However, slow adoption of advanced hematology instruments in the emerging economies, hematology product recalls, and the high cost of hematology analyzers are restraining the growth of this market. Rapid growth of hematology market in emerging countries such as India, China and Brazil; introduction of digital imaging systems in hematology laboratories; and growing use of microfluidics technology in hematology analyzer are creating opportunities for the growth of the hematology analyzers and reagents market in these regions.
In this report, the global hematology market has been segmented on the basis of type of product (hematology instruments and consumables) & services and by end-users (commercial organizations, stand alone hospitals, research institutes, and clinical testing labs).
Key Topics Covered:
2 Executive Summary
3 Premium Insights
4 Market Overview
5 Industry Trends
6 Hematology Products and Services Market
7 Global Hematology Market, By End Users
8 Geographic Analysis
9 Competitive Landscape
10 Company Profiles
- Abbott Laboratories
- Beckman Coulter
- Bio-Rad Laboratories
- Boule Diagnostics Ab
- Horiba, Ltd.
- Mindray Medical International Limited
- Nihon Kohden Corporation
- Roche Diagnostics
- Siemens Healthcare
- Sysmex Corporation
For more information visit http://www.researchandmarkets.com/research/xrc3xb/hematology
Media Contact: Laura Wood, +353-1-481-1716, [email protected]
Bert Loomis was a visionary. This general session will highlight how Bert Loomis and people like him inspire us to build great things with small inventions. In their general session at 19th Cloud Expo, Harold Hannon, Architect at IBM Bluemix, and Michael O'Neill, Strategic Business Development at Nvidia, will discuss the accelerating pace of AI development and how IBM Cloud and NVIDIA are partnering to bring AI capabilities to "every day," on-demand. They will also review two "free infrastruct...
Oct. 28, 2016 10:32 AM EDT
The Internet of Things (IoT), in all its myriad manifestations, has great potential. Much of that potential comes from the evolving data management and analytic (DMA) technologies and processes that allow us to gain insight from all of the IoT data that can be generated and gathered. This potential may never be met as those data sets are tied to specific industry verticals and single markets, with no clear way to use IoT data and sensor analytics to fulfill the hype being given the IoT today.
Oct. 28, 2016 10:30 AM EDT Reads: 2,928
Oct. 28, 2016 09:15 AM EDT Reads: 11,625
Oct. 28, 2016 09:00 AM EDT Reads: 2,021
Oct. 28, 2016 08:30 AM EDT Reads: 707
Oct. 28, 2016 08:00 AM EDT Reads: 5,093
Oct. 28, 2016 08:00 AM EDT Reads: 922
Oct. 28, 2016 08:00 AM EDT Reads: 1,072
Oct. 28, 2016 08:00 AM EDT Reads: 1,644
Oct. 28, 2016 08:00 AM EDT Reads: 3,526
Oct. 28, 2016 07:15 AM EDT Reads: 1,120
Oct. 28, 2016 07:15 AM EDT Reads: 1,121
Oct. 28, 2016 07:00 AM EDT Reads: 3,778
Oct. 28, 2016 07:00 AM EDT Reads: 1,173
Oct. 28, 2016 07:00 AM EDT Reads: 597